Clinical Trial Update: Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis

View source ↗

Summary

This clinical trial update reports on residual anti-pneumococcal immunity following pneumococcal vaccination in patients with ANCA-associated vasculitis. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Pneumococcal Infection

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumococcal Infection, ANCA-associated Vasculitis | Status: COMPLETED